Lamivudine 60505-3252-03
- Manufacturer
- Apotex Corp.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 2, 2011
- Listing Expires
- December 31, 2026
- Application
- ANDA091606
Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
60505-3252-03Selected30 TABLET, FILM COATED in 1 BOTTLE (60505-3252-3)
Other packages for this product(1)
1000 TABLET, FILM COATED in 1 BOTTLE (60505-3252-8)